IRMD - Company ID 0001325618
IRADIMED CORP trades as IRMD and has a market capitalization of $1.24 B, making it the #2497 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $83.81M, up 14.4% from the prior year and net income of $22.48M. This page tracks IRADIMED CORP through 760 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-11
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years IRADIMED CORP's revenue grew from $32.50M to $83.81M, a compound annual growth rate of 11.1%. Net profit margin expanded from 22.2% to 26.8% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-20 |
| SCHEDULE 13G/A | - | 2026-05-14 |
| Insider trade | 4 | 2026-05-13 |
| Insider trade | 4 | 2026-05-06 |
| Quarterly report | 10-Q | 2026-05-01 |
| Major company event | 8-K | 2026-05-01 |
| Annual report to shareholders | ARS | 2026-04-30 |
| Proxy statement | DEF 14A | 2026-04-30 |
The largest companies sharing IRADIMED CORP's SEC industry classification (surgical & medical instruments & apparatus).
IRADIMED CORP (IRMD) has a market capitalization of $1.24 B as of 2026-07-11, ranking #2497 among US-listed companies.
IRADIMED CORP reported revenue of $83.81M for fiscal year 2025, an increase of 14.4% year over year.
Yes. IRADIMED CORP reported net income of $22.48M in its latest fiscal year.